Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos

Reproductive Toxicology

Volumn 23, Issue 1, 2007, Pages 63-74

  Gäreskog, Mattias ^a   Cederberg, Jonas ^a   Eriksson, Ulf J ^a   Wentzel, Parri ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Bax; Bcl 2; Caspase 3; Diabetes in pregnancy; Embryopathy; Rat

Indexed keywords

ACETYLCYSTEINE; APOPTOSIS INHIBITOR; CASPASE 3; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYO DEATH; EMBRYO DEVELOPMENT; EMBRYOPATHY; ENZYME ACTIVATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MATERNAL DIABETES MELLITUS; NONHUMAN; ORGANOGENESIS; RAT; TERATOGENICITY; VITAL STAIN;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; EMBRYO; EMBRYONIC DEVELOPMENT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUCOSE; IMMUNOENZYME TECHNIQUES; ORGAN CULTURE TECHNIQUES; PREGNANCY; PREGNANCY IN DIABETICS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS;

EID: 33845912680     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2006.08.009     Document Type: Article

References (54)

1. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7 (1971) 61-70
2. Becerra J.E., Khoury M.J., Cordero J.F., and Erickson J.D. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85 (1990) 1-9
3. Eriksson U.J., and Borg L.A.H. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34 (1991) 325-331
4. Eriksson U.J., and Simán C.M. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in the offspring. Diabetes 45 (1996) 1497-1502
5. Wentzel P., Thunberg L., and Eriksson UJ. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40 (1997) 7-14
6. Wentzel P., Wentzel C.R., Gareskog M.B., and Eriksson U.J. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 63 (2001) 193-201
7. Hiramatsu Y., Sekiguchi N., Hayashi M., Isshiki K., Yokota T., King G.L., et al. Diacylglycerol production and protein kinase C activity are increased in a mouse model of diabetic embryopathy. Diabetes 51 (2002) 2804-2810
8. Goldman A.S., Baker L., Piddington R., Marx B., Herold R., and Egler J. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proceedings of the National Academy of Sciences of the United States of America, vol. 82 (1985) 8227-8231
9. Phelan S.A., Ito M., and Loeken M.R. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46 (1997) 1189-1197
10. Moley K., Chi M., Knudson C., Korsmeyer S., and Mueckler M. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nature Med 4 (1998) 1421-1424
11. Sun F., Kawasaki E., Akazawa S., Hishikawa Y., Sugahara K., Kamihira S., et al. Apoptosis and its pathway in early post-implantation embryos of diabetic rats. Diabetes Res Clin Pract 67 (2005) 110-118
12. Wentzel P., and Eriksson U.J. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes 47 (1998) 677-684
13. Wentzel P., Welsh N., and Eriksson U.J. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered PGE2 levels in rat embryos exposed to a diabetic environment. Diabetes 48 (1999) 813-820
14. Wentzel P., and Eriksson U.J. A diabetes-like environment increases malformation rate and diminishes prostaglandin E(2) in rat embryos: reversal by administration of vitamin E and folic acid. Birth Defects Res A Clin Mol Teratol 73 (2005) 506-511
15. Glucksmann A. Cell death in normal vertebrate ontogeny. Biol Rev Camb Philos Soc 26 (1951) 59-86
16. Sanders E.J., and Wride M.A. Programmed cell death in development. Int Rev Cytol 163 (1995) 105-173
17. Novack D.V., and Korsmeyer S.J. Bcl-2 protein expression during murine development. Am J Pathol 145 (1994) 61-73
18. Metcalfe A.D., Hunter H.R., Bloor D.J., Lieberman B.A., Picton H.M., Leese H.J., et al. Expression of 11 members of the BCL-2 family of apoptosis regulatory molecules during human preimplantation embryo development and fragmentation. Mol Reprod Dev 68 (2004) 35-50
19. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Negishi I., et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267 (1995) 1506-1510
20. Shindler K.S., Latham C.B., and Roth K.A. Bax deficiency prevents the increased cell death of immature neurons in Bcl-x-deficient mice. J Neurosci 17 (1997) 3112-3119
21. Woo M., Hakem R., Soengas M.S., Duncan G.S., Shahinian A., Kagi D., et al. Essential contribution of Caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12: (1998) 806-819
22. Cartwright M.M., and Smith SM. Increased cell death and reduced neural crest cell numbers in ethanol- exposed embryos: partial basis for the fetal alcohol syndrome phenotype. Alcohol Clin Exp Res 19 (1995) 378-386
23. Menegola E., Broccia M.L., Di Renzo F., and Giavini E. Acetaldehyde in vitro exposure and apoptosis: a possible mechanism of teratogenesis. Alcohol 23 (2001) 35-39
24. Kim W.K., and Mirkes PE. Alterations in mitochondrial morphology are associated with hyperthermia-induced apoptosis in early postimplantation mouse embryos. Birth Defects Res A Clin Mol Teratol 67 (2003) 929-940
25. Mirkes P.E., and Little SA. Teratogen-induced cell death in postimplantation mouse embryos: differential tissue sensitivity and hallmarks of apoptosis. Cell Death Differ 5 (1998) 592-600
26. Sidhu J.S., Ponce R.A., Vredevoogd M.A., Yu X., Gribble E., Hong S.W., et al. Cell cycle inhibition by sodium arsenite in primary embryonic rat midbrain neuroepithelial cells. Toxicol Sci 89 (2006) 475-484
27. Reece E.A., Ma X.D., Zhao Z., Wu Y.K., and Dhanasekaran D. Aberrant patterns of cellular communication in diabetes-induced embryopathy in rats: II, apoptotic pathways. Am J Obstet Gynecol 192 (2005) 967-972
28. Akazawa S. Diabetic embryopathy: studies using a rat embryo culture system and an animal model. Congenit Anom (Kyoto) 45 (2005) 73-79
29. Zhao Z., and Reece E.A. Experimental mechanisms of diabetic embryopathy and strategies for developing therapeutic interventions. J Soc Gynecol Investig 12 (2005) 549-557
30. Reece E.A., Wu Y.K., Zhao Z., and Dhanasekaran D. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. Am J Obstet Gynecol 194 (2006) 580-585
31. Pampfer S., de Hertogh R., Vanderheyden I., Michiels B., and Vercheval M. Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes 39 (1990) 471-476
32. Loeken M.R. Advances in understanding the molecular causes of diabetes-induced birth defects. J Soc Gynecol Investig 13 (2006) 2-10
33. 2001 (2000) Report of the AVMA Panel on Euthanasia. J Am Vet Med Assoc 218:669-96.
34. New DAT (1978) Whole embryo culture and the study of mammalian embryos during embryogenesis. Biol Rev 53:81-122.
35. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
36. Fine E.L., Horal M., Chang T.I., Fortin G., and Loeken MR. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes 48 (1999) 2454-2462
37. Lademann U., Cain K., Gyrd-Hansen M., Brown D., Peters D., and Jaattela M. Diarylurea compounds inhibit Caspase activation by preventing the formation of the active 700-kDa apoptosome complex. Mol Cell Biol 23 (2003) 7829-7837
38. Engerman R.L., and Kern T.S. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36 (1987) 808-812
39. Forsberg H., Eriksson U.J., and Welsh N. Apoptosis in embryos of diabetic rats. Pharmacol Toxicol 83 (1998) 104-111
40. El-Bassiouni E.A., Helmy M.H., Abou Rawash N., El-Zoghby S.M., Kamel M.A., and Abou Raya A.N. Embryopathy in experimental diabetic gestation: assessment of PGE2 level, gene expression of cyclooxygenases and apoptosis. Br J Biomed Sci 62 (2005) 161-165
41. Suhonen L., Hiilesmaa V., and Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 43 (2000) 79-82
42. Shepard T., Tanimura T., and Park H. Glucose absorption and utilization by rat embryos. Int J Develop Biol 41 (1997) 307-314
43. Yang X., Borg L.A.H., and Eriksson U.J. Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272 (1997) E173-E180
44. Peet J., and Sadler T. Mouse embryonic cardiac metabolism under euglycemic and hypoglycemic conditions. Teratology 54 (1996) 20-26
45. Wentzel P., and Eriksson U.J. Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats. Eur J Endocrinol 134 (1996) 446-459
46. Simán C.M., Gittenberger-De Groot A.C., Wisse B., and Eriksson U.J. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal Vitamin E treatment. Teratology 61 (2000) 355-367
47. Molin D.G., Roest P.A., Nordstrand H., Wisse L.J., Poelmann R.E., Eriksson U.J., et al. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats. Birth Defects Res A Clin Mol Teratol 70 (2004) 927-938
48. Yang X., Borg L.A.H., and Eriksson U.J. Altered mitochondrial morphology of rat embryos in diabetic pregnancy. Anatom Record 241 (1995) 255-267
49. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
50. Acehan D., Jiang X., Morgan D.G., Heuser J.E., Wang X., and Akey C.W. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 9 (2002) 423-432
51. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengeller Z., Szabo C., et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112 (2003) 1049-1057
52. Yang X., Borg L.A.H., Simán C.M., and Eriksson U.J. Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos. The Anatom Record 251 (1998) 303-315
53. Wentzel P., Ejdesjo A., and Eriksson U.J. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos. Diabetes 52 (2003) 1222-1228
54. Ray J.G., Vermeulen M.J., Meier C., and Wyatt P.R. Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes. QJM 97 (2004) 651-653